Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

MITSUBISHI PLASTICS

KOSE

Chugoku Marine Paints

日油

DAISO

AIR WATER

POLA ORBIS HOLDINGS

SANKO GOSEI

MUTO SEIKO CO.

ZEON

FUJIKURA KASEI

KUREHA

MATSUMOTO YUSHI-SEIYAKU

C.Uyemura

日本新薬

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

メルコホールディングス

日本セラミック

日本セラミック

日本セラミック

日本セラミック

Financial Indicator Details: タキロン (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: タキロン (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	-1.48% (-12.05%)	1.89% (-0.50%)	3.71% (1.53%)	2.86% (-1.67%)	5.00% (3.05%)
C/F margin (Industry Average)	6.19% (-3.31%)	6.90% (8.51%)	11.27% (7.04%)	4.80% (6.35%)	9.78% (8.25%)
ROA (Industry Average)	-1.30% (0.52%)	1.53% (1.04%)	3.23% (2.07%)	2.48% (0.06%)	4.35% (2.71%)
ROE (Industry Average)	-2.72% (-1.43%)	2.93% (0.03%)	6.07% (2.96%)	4.67% (4.68%)	7.56% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	2.99% (5.01%)	0.51% (2.61%)	2.15% (-0.40%)	7.58% (8.16%)
Sales growth (Industry Average)	- (-)	-12.93% (-2.67%)	5.77% (5.36%)	2.13% (1.07%)	-0.54% (2.24%)
Net profit growth (Industry Average)	- (-)	210.97% (203.46%)	107.87% (63.25%)	-21.37% (3.89%)	74.10% (90.38%)
Operating C/F growth (Industry Average)	- (-)	-2.96% (275.10%)	72.82% (35.09%)	-56.50% (-6.09%)	102.50% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	48.02% (53.80%)	52.19% (54.51%)	53.20% (55.00%)	53.07% (53.59%)	57.56% (56.30%)
Liquidity ratio (Industry Average)	162.45% (217.72%)	183.88% (225.70%)	192.33% (237.55%)	197.59% (239.89%)	219.82% (236.21%)
C/F ratio current liabilities (Industry Average)	605.61% (777.21%)	535.85% (303.31%)	300.17% (434.79%)	712.70% (929.73%)	321.93% (573.30%)
Quick ratio (Industry Average)	115.80% (138.97%)	134.74% (148.85%)	138.41% (156.17%)	141.92% (160.84%)	164.24% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	112.78day (83.89day)	129.65day (94.27day)	126.74day (93.96day)	138.74day (97.92day)	134.34day (98.27day)
Inventory turnover (Industry Average)	55.21day (54.45day)	56.51day (52.58day)	57.82day (52.64day)	60.56day (56.59day)	54.98day (58.68day)
Payable turnover (Industry Average)	70.04day (45.01day)	72.24day (49.82day)	76.47day (49.52day)	76.33day (52.10day)	69.00day (51.12day)
Working capita turnover (Industry Average)	97.96day (93.32day)	113.92day (97.02day)	108.09day (97.08day)	122.97day (102.41day)	120.32day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	14.93% (34.57%)	25.63% (1.49%)	-13.21% (-3.85%)	14.56% (21.16%)
Dividend Yield (Industry Average)	3.16% (3.20%)	1.72% (1.93%)	1.59% (2.17%)	2.75% (2.45%)	2.11% (2.07%)
PER (Industry Average)	-17.64% (25.22%)	18.27% (23.06%)	11.04% (16.22%)	12.18% (29.19%)	8.02% (16.58%)
PBR (Industry Average)	0.48% (0.86%)	0.53% (1.06%)	0.67% (1.04%)	0.56% (0.95%)	0.60% (1.08%)
PCFR (Industry Average)	4.22% (7.18%)	5.00% (9.23%)	3.63% (-2.43%)	7.25% (9.50%)	4.10% (7.56%)
PSR (Industry Average)	0.26% (0.77%)	0.34% (0.88%)	0.41% (1.10%)	0.34% (0.90%)	0.40% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	-2.22% (-27.66%)	2.88% (-4.34%)	4.66% (-5.37%)	2.68% (-10.69%)	5.91% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	-1.49% (0.52%)	1.65% (0.92%)	2.75% (1.42%)	1.61% (-0.27%)	3.42% (1.53%)
ROE (Industry Average)	-2.52% (-0.84%)	2.74% (-0.46%)	4.71% (1.81%)	2.84% (3.42%)	5.68% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	1.83% (3.64%)	3.12% (3.03%)	0.28% (0.04%)	5.25% (3.91%)
Sales growth (Industry Average)	- (-)	-14.83% (-3.48%)	9.75% (6.70%)	5.15% (0.75%)	-4.63% (-1.74%)
Net profit growth (Industry Average)	- (-)	210.78% (166.48%)	77.07% (43.48%)	-39.40% (-47.04%)	109.92% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	59.08% (56.79%)	60.32% (57.65%)	58.53% (57.17%)	56.70% (55.93%)	60.26% (57.57%)
Liquidity ratio (Industry Average)	220.07% (337.22%)	239.93% (276.75%)	224.94% (266.94%)	223.60% (314.47%)	- (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	144.99% (167.28%)	151.02% (183.78%)	131.91% (174.83%)	127.82% (228.06%)	- (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	119.73day (87.55day)	144.20day (98.39day)	136.80day (95.88day)	149.75day (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	55.51day (50.17day)	55.66day (48.43day)	58.51day (47.43day)	61.28day (50.67day)	- (38.21day)
Payable turnover (Industry Average)	74.11day (45.70day)	93.36day (51.63day)	95.85day (51.13day)	95.00day (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	101.13day (92.02day)	106.49day (95.19day)	99.46day (92.19day)	116.04day (95.69day)	- (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	14.93% (34.46%)	25.63% (3.11%)	-13.21% (-3.30%)	14.56% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	-21.31% (34.12%)	22.10% (27.80%)	15.68% (13.58%)	22.46% (22.26%)	12.25% (26.42%)
PBR (Industry Average)	0.53% (0.97%)	0.60% (1.21%)	0.73% (1.17%)	0.63% (1.08%)	0.69% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	0.47% (3.42%)	0.63% (4.34%)	0.73% (3.67%)	0.60% (4.37%)	0.72% (10.14%)

Financial Indicator Details: タキロン

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	-1.48%	1.89%	3.71%	2.86%	5.00%
C/F margin	6.19%	6.90%	11.27%	4.80%	9.78%
ROA	-1.30%	1.53%	3.23%	2.48%	4.35%
ROE	-2.72%	2.93%	6.07%	4.67%	7.56%
Recurring margin	0.53%	4.08%	6.06%	6.37%	7.11%
EBIT margin	-0.40%	3.47%	5.44%	6.10%	8.44%
EBITDA margin	5.17%	9.58%	10.58%	10.91%	12.80%
NOPAT margin	-0.24%	2.08%	3.26%	3.66%	5.06%
Sales SG rates	71.71%	66.24%	66.13%	66.72%	66.51%
Sales SG&A rates	26.92%	29.07%	27.54%	27.06%	26.52%
Sales R&D expenses rates	1.31%	1.37%	1.29%	1.21%	1.21%
Sales depreciation rates	5.57%	6.11%	5.14%	4.80%	4.36%
Capital expenditures net sales ratio	-3.77%	-2.80%	-3.54%	-4.83%	-3.03%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-0.56%	-10.32%	-11.05%	40.25%
Equity growth	-	2.99%	0.51%	2.15%	7.58%
Total assets growth	-	-5.24%	-1.38%	2.39%	-0.80%
Sales growth	-	-12.93%	5.77%	2.13%	-0.54%
Net profit growth	-	210.97%	107.87%	-21.37%	74.10%
Operating C/F growth	-	-2.96%	72.82%	-56.50%	102.50%
Recurring profit growth	-	570.12%	57.01%	7.23%	11.11%
EBIT growth	-	856.55%	65.77%	14.46%	37.47%
EBITDA growth	-	61.30%	16.80%	5.27%	16.63%
NOPAT growth	-	856.55%	65.77%	14.46%	37.47%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	48.02%	52.19%	53.20%	53.07%	57.56%
Liquidity ratio	162.45%	183.88%	192.33%	197.59%	219.82%
C/F ratio current liabilities	605.61%	535.85%	300.17%	712.70%	321.93%
Quick ratio	115.80%	134.74%	138.41%	141.92%	164.24%
Fixed ratio	71.66%	62.76%	59.57%	57.65%	51.75%
D/E ratio	28.68%	20.98%	11.41%	12.08%	8.91%
Loan to Value Ratio	13.77%	10.95%	6.07%	6.41%	5.12%
Business investment C/F ratio	-61.00%	-40.57%	-31.40%	-100.67%	-31.01%
Liabilities with interest growth	-	-24.65%	-45.32%	8.19%	-20.69%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	45.76day	52.26day	44.31day	38.59day	54.42day
Receivables turnover	112.78day	129.65day	126.74day	138.74day	134.34day
Inventory turnover	55.21day	56.51day	57.82day	60.56day	54.98day
Fixed assets turnover	142.35day	147.51day	133.03day	128.78day	125.05day
Total asset turnover	413.66day	450.23day	419.76day	420.83day	419.73day
Payable turnover	70.04day	72.24day	76.47day	76.33day	69.00day
Capital turnover	76.47day	87.84day	83.04day	81.31day	81.76day
Equity turnover	198.64day	235.00day	223.32day	223.37day	241.63day
Working capita turnover	97.96day	113.92day	108.09day	122.97day	120.32day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 9 B	¥ 9 B	¥ 8 B	¥ 7 B	¥ 10 B
Accounts receivable-trade	¥ 22 B	¥ 22 B	¥ 23 B	¥ 25 B	¥ 24 B
Other Current Assets	¥ 35 B	¥ 33 B	¥ 35 B	¥ 38 B	¥ 36 B
Current Assets	¥ 44 B	¥ 42 B	¥ 43 B	¥ 46 B	¥ 46 B
Tangible Assets	¥ 28 B	¥ 25 B	¥ 24 B	¥ 24 B	¥ 23 B
Intangible Assets	¥ 854 M	¥ 492 M	¥ 915 M	¥ 762 M	¥ 568 M
Investment etc.	¥ 8 B	¥ 8 B	¥ 8 B	¥ 7 B	¥ 7 B
Total Assets	¥ 82 B	¥ 77 B	¥ 76 B	¥ 78 B	¥ 77 B
Current Liabilities	¥ 27 B	¥ 23 B	¥ 22 B	¥ 23 B	¥ 21 B
Fixed Liabilities	¥ 15 B	¥ 13 B	¥ 13 B	¥ 13 B	¥ 11 B
Liabilities with interest	¥ 11 B	¥ 8 B	¥ 4 B	¥ 5 B	¥ 4 B
Net Assets	¥ 39 B	¥ 40 B	¥ 40 B	¥ 41 B	¥ 44 B
Capital stock	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B
Capital surplus etc.	¥ 24 B	¥ 25 B	¥ 25 B	¥ 26 B	¥ 29 B
Liabilities and net assets	¥ 82 B	¥ 77 B	¥ 76 B	¥ 78 B	¥ 77 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 72 B	¥ 63 B	¥ 66 B	¥ 68 B	¥ 67 B
Cost of Sales	¥ 51 B	¥ 41 B	¥ 44 B	¥ 45 B	¥ 45 B
Gross profit	¥ 20 B	¥ 21 B	¥ 22 B	¥ 22 B	¥ 22 B
Other income	¥ 391 M	¥ 392 M	¥ 626 M	¥ 359 M	¥ 1 B
SG&A	¥ 19 B	¥ 18 B	¥ 18 B	¥ 18 B	¥ 17 B
Other expenses	¥ 2 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Net income	¥ -1 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 3 B
Operating income	¥ 987 M	¥ 2 B	¥ 4 B	¥ 4 B	¥ 4 B
Ordinary Income	¥ 385 M	¥ 2 B	¥ 4 B	¥ 4 B	¥ 4 B
EBITDA	¥ 3 B	¥ 6 B	¥ 7 B	¥ 7 B	¥ 8 B
Income before income taxes	¥ -454 M	¥ 2 B	¥ 3 B	¥ 4 B	¥ 5 B
Depreciation	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 2 B
R&D expenses	¥ 955 M	¥ 866 M	¥ 863 M	¥ 827 M	¥ 826 M
Income taxes	¥ 926 M	¥ 586 M	¥ 1 B	¥ 2 B	¥ 2 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 4 B	¥ 4 B	¥ 7 B	¥ 3 B	¥ 6 B
Investment CF	¥ -2 B	¥ -750 M	¥ -3 B	¥ -3 B	¥ -1 B
Financial CF	¥ -243 M	¥ -3 B	¥ -4 B	¥ -709 M	¥ -1 B
Foreign Exchange Effects	¥ -47 M	¥ 5 M	¥ -14 M	¥ -4 M	¥ 9 M
Net Change in Cash	¥ 1 B	¥ -47 M	¥ -937 M	¥ -934 M	¥ 2 B
Free CF	¥ 1 B	¥ 3 B	¥ 3 B	¥ -221 M	¥ 4 B
Capital expenditures	¥ -2 B	¥ -1 B	¥ -2 B	¥ -3 B	¥ -2 B
Cash dividends paid	¥ -601 M	¥ -377 M	¥ -438 M	¥ -654 M	¥ -577 M
Repayment loans	¥ -3 B	¥ -1 B	¥ -1 B	¥ -600 M	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -592 M	¥ -370 M	¥ -438 M	¥ -652 M	¥ -573 M
Net income	¥ -1 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 3 B
Purchase of treasury stock	¥ -8 M	¥ -235 M	¥ -107 M	¥ -281 M	¥ -1 M
Other Change in Stockholders Equity	¥ -2 M	¥ 1 M	¥ -1 M	¥ 37 M	¥ -62 M
Other Change in Net Assets	¥ -976 M	¥ 593 M	¥ -1 B	¥ -175 M	¥ 405 M
Net Change in Net Assets	¥ -2 B	¥ 1 B	¥ 209 M	¥ 879 M	¥ 3 B

Financial Indicator Details: タキロン

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	-2.22%	2.88%	4.66%	2.68%	5.91%
C/F margin	-	-	-	-	-
ROA	-1.49%	1.65%	2.75%	1.61%	3.42%
ROE	-2.52%	2.74%	4.71%	2.84%	5.68%
Recurring margin	1.06%	3.63%	7.37%	7.17%	6.77%
EBIT margin	-0.78%	3.20%	6.25%	6.98%	-
EBITDA margin	-0.78%	3.20%	6.25%	6.98%	-
NOPAT margin	-0.46%	1.92%	3.75%	4.19%	-
Sales SG rates	71.54%	66.42%	64.97%	66.68%	94.08%
Sales SG&A rates	27.17%	29.84%	27.62%	26.51%	-
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	-	-	-	-	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-8.65%	6.49%	-9.38%	-100.00%
Equity growth	-	1.83%	3.12%	0.28%	5.25%
Total assets growth	-	-0.26%	6.28%	3.52%	-0.97%
Sales growth	-	-14.83%	9.75%	5.15%	-4.63%
Net profit growth	-	210.78%	77.07%	-39.40%	109.92%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	192.00%	122.64%	2.24%	-9.87%
EBIT growth	-	449.84%	113.88%	17.54%	-100.00%
EBITDA growth	-	449.84%	113.88%	17.54%	-100.00%
NOPAT growth	-	449.84%	113.88%	17.54%	-100.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	59.08%	60.32%	58.53%	56.70%	60.26%
Liquidity ratio	220.07%	239.93%	224.94%	223.60%	-
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	144.99%	151.02%	131.91%	127.82%	-
Fixed ratio	47.68%	42.72%	38.24%	35.51%	-
D/E ratio	5.95%	5.28%	4.31%	5.65%	-
Loan to Value Ratio	3.51%	3.19%	2.52%	3.20%	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-9.52%	-15.78%	31.25%	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	57.86day	62.06day	60.22day	51.89day	-
Receivables turnover	119.73day	144.20day	136.80day	149.75day	-
Inventory turnover	55.51day	55.66day	58.51day	61.28day	-
Fixed assets turnover	153.17day	164.09day	138.00day	122.24day	-
Total asset turnover	543.68day	636.67day	616.49day	606.95day	630.25day
Payable turnover	74.11day	93.36day	95.85day	95.00day	-
Capital turnover	138.33day	162.42day	147.98day	140.73day	-
Equity turnover	321.22day	384.09day	360.87day	344.18day	379.85day
Working capita turnover	101.13day	106.49day	99.46day	116.04day	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 6 B	¥ 5 B	¥ 6 B	¥ 5 B	-
Accounts receivable-trade	¥ 13 B	¥ 13 B	¥ 14 B	-	-
Other Current Assets	¥ 23 B	¥ 24 B	¥ 28 B	¥ 32 B	-
Current Assets	¥ 29 B	¥ 30 B	¥ 34 B	-	-
Tangible Assets	¥ 16 B	¥ 15 B	¥ 14 B	¥ 13 B	-
Intangible Assets	¥ 315 M	¥ 218 M	¥ 387 M	¥ 374 M	-
Investment etc.	¥ 12 B	¥ 13 B	¥ 14 B	¥ 13 B	¥ 64 B
Total Assets	¥ 59 B	¥ 59 B	¥ 63 B	¥ 65 B	¥ 64 B
Current Liabilities	¥ 13 B	¥ 12 B	¥ 15 B	¥ 17 B	¥ 25 B
Fixed Liabilities	¥ 10 B	¥ 10 B	¥ 10 B	¥ 11 B	-
Liabilities with interest	¥ 2 B	¥ 1 B	¥ 1 B	¥ 2 B	-
Net Assets	¥ 35 B	¥ 35 B	¥ 37 B	¥ 37 B	¥ 39 B
Capital stock	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B	-
Capital surplus etc.	¥ 20 B	¥ 20 B	¥ 21 B	¥ 21 B	¥ 39 B
Liabilities and net assets	¥ 59 B	¥ 59 B	¥ 63 B	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 40 B	¥ 34 B	¥ 37 B	¥ 39 B	¥ 37 B
Cost of Sales	¥ 28 B	¥ 22 B	¥ 24 B	¥ 26 B	¥ 35 B
Gross profit	¥ 11 B	¥ 11 B	¥ 13 B	¥ 13 B	¥ 2 B
Other income	¥ 826 M	¥ 985 M	¥ 830 M	¥ 651 M	-
SG&A	¥ 10 B	¥ 10 B	¥ 10 B	¥ 10 B	-
Other expenses	¥ 2 B	¥ 1 B	¥ 1 B	¥ 2 B	-
Net income	¥ -890 M	¥ 986 M	¥ 1 B	¥ 1 B	¥ 2 B
Operating income	¥ 512 M	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Ordinary Income	¥ 425 M	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
EBITDA	¥ -313 M	¥ 1 B	¥ 2 B	¥ 2 B	-
Income before income taxes	¥ -314 M	¥ 1 B	¥ 2 B	-	-
Depreciation	-	-	-	-	-
R&D expenses	-	-	-	-	-
Income taxes	¥ 575 M	¥ 100 M	¥ 596 M	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -592 M	¥ -370 M	¥ -438 M	-	-
Net income	¥ -890 M	¥ 986 M	¥ 1 B	-	-
Purchase of treasury stock	¥ -8 M	¥ -235 M	¥ -107 M	-	-
Other Change in Stockholders Equity	¥ -1 M	¥ 1 M	-	-	-
Other Change in Net Assets	¥ -548 M	¥ 264 M	¥ -79 M	-	-
Net Change in Net Assets	¥ -2 B	¥ 646 M	¥ 1 B	-	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: タキロン (Annual )

Statement Type

Annual : タキロン

First quarter : タキロン

Second quarter : タキロン

Third quarter : タキロン

Analysis Menu

Outline : タキロン

Statement : タキロン

Rating : タキロン

Indicator : タキロン

Download : タキロン

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Osaka - EDIUNET Prefectures

Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
タキロン	4215	TSE 1st	Chemicals	3	Annual	BBB

Related Company

SATO PHARMACEUTICAL (Sales ¥ 38 B)

タキロン (Sales ¥ 67 B)

和光純薬工業 (Sales ¥ 74 B)

Eisai (Sales ¥ 573 B)

KOSE (Sales ¥ 170 B)

MUTO SEIKO CO. (Sales ¥ 24 B)

Sumitomo Seika Chemicals (Sales ¥ 70 B)

DAINICHISEIKA COLOR & CHEMICALS MFG. (Sales ¥ 151 B)

ZERIA PHARMACEUTICAL (Sales ¥ 53 B)

C.Uyemura (Sales ¥ 37 B)

MATSUMOTO YUSHI-SEIYAKU (Sales ¥ 27 B)

POLA ORBIS HOLDINGS (Sales ¥ 180 B)

DAISO (Sales ¥ 83 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .